PKCθ pseudosubstrate peptide inhibitor, myristoylated

O=C([C@@H](NC(CCCCCCCCCCCCC)=O)CC(C)C)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CS)=O)CCCCN)=O)C(C)C)=O)CC1=CNC=N1)=O)CC2=CNC=N2)=O)C(C)C)=O)CCCCN)=O)C)=O)CCC(N)=O)=O)CCCCN)=O)[C@H](CC)C)=O)C)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CC3=CNC=N3

[1]Koon HW, et al. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther. 2005 Sep;314 (3) :1393-400.